LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 1 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 1. - Dataset (ID:20309)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 55.99 | 771.67 | 6940 | 7690 | 0.9025 | 0.9391 | MN20160304_L01 | E09 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 55.99 | 771.67 | 7671 | 7690 | 0.9975 | 0.9985 | MN20160304_L01 | J07 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 58.21 | 771.67 | 7251 | 8085 | 0.8968 | 0.9367 | MN20160304_L01 | E09 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 58.21 | 771.67 | 8014 | 8085 | 0.9912 | 0.9948 | MN20160304_L01 | J07 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 60.44 | 771.67 | 7609 | 8530 | 0.8920 | 0.9351 | MN20160304_L01 | E09 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 60.44 | 771.67 | 8334 | 8530 | 0.9770 | 0.9866 | MN20160304_L01 | J07 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 62.66 | 771.67 | 7875 | 8978 | 0.8771 | 0.9273 | MN20160304_L01 | E09 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 62.66 | 771.67 | 8564 | 8978 | 0.9538 | 0.9735 | MN20160304_L01 | J07 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 64.88 | 771.67 | 8027 | 9447 | 0.8497 | 0.9119 | MN20160304_L01 | E09 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 64.88 | 771.67 | 8738 | 9447 | 0.9249 | 0.9573 | MN20160304_L01 | J07 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 67.10 | 771.67 | 8261 | 9800 | 0.8429 | 0.9089 | MN20160304_L01 | E09 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 67.10 | 771.67 | 8930 | 9800 | 0.9112 | 0.9499 | MN20160304_L01 | J07 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 69.32 | 771.67 | 8372 | 10212 | 0.8198 | 0.8962 | MN20160304_L01 | E09 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 69.32 | 771.67 | 9070 | 10212 | 0.8882 | 0.9373 | MN20160304_L01 | J07 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 71.54 | 771.67 | 8544 | 10532 | 0.8112 | 0.8920 | MN20160304_L01 | E09 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 71.54 | 771.67 | 9219 | 10532 | 0.8753 | 0.9306 | MN20160304_L01 | J07 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 73.76 | 771.67 | 8611 | 10851 | 0.7935 | 0.8823 | MN20160304_L01 | E09 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 73.76 | 771.67 | 9341 | 10851 | 0.8608 | 0.9229 | MN20160304_L01 | J07 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 76.02 | 771.67 | 8636 | 11106 | 0.7776 | 0.8734 | MN20160304_L01 | E09 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 76.02 | 771.67 | 9365 | 11106 | 0.8432 | 0.9133 | MN20160304_L01 | J07 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 78.25 | 771.67 | 8813 | 11367 | 0.7753 | 0.8730 | MN20160304_L01 | E09 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 78.25 | 771.67 | 9379 | 11367 | 0.8251 | 0.9033 | MN20160304_L01 | J07 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 80.48 | 771.67 | 8786 | 11685 | 0.7519 | 0.8597 | MN20160304_L01 | E09 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 80.48 | 771.67 | 9352 | 11685 | 0.8003 | 0.8896 | MN20160304_L01 | J07 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 82.69 | 771.67 | 8758 | 11974 | 0.7314 | 0.8480 | MN20160304_L01 | E09 |